Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Product Insert, Amiloride HCl Tablets
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Psoriasis during natalizumab treatment for multiple sclerosis.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
A touch of MS: Therapeutic mislabeling.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Fatal Neuroinflammation in a Case of Multiple Sclerosis with Anti-Natalizumab Antibodies.

Pages